Molecular Genotyping in Myeloid Malignancies: Where Is the Biology Leading Us?
Dr. Olatoyosi Odenike, associate professor of medicine, outlines the evolving role of molecular profiling in myeloid neoplasia and discusses the opportunities and challenges for drug development efforts.
Published
June 8, 2016
Created by
Related Presenters
Associate Professor of Medicine
Dr. Olatoyosi Sobulo Odenike is an expert in the care of adults with leukemia, chronic myeloproliferative diseases, and myelodysplastic syndromes. She specializes in all types of treatment for these diseases, including blood and bone marrow ...